Functional Electrical Stimulation (FES) Assisted Walking: Enhancement of Walking Function After Stroke

Stroke Clinical Trial

Official title:

Functional Electrical Stimulation (FES)-Assisted Walking: Enhancement of Voluntary Walking Function Among Persons With Severe Hemiplegia Post-Stroke

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00552916
• Other study ID #: SRA 5973
• Status: Recruiting
• Phase: Phase 4
• First received: November 1, 2007
• Last updated: August 19, 2008
• Start date: October 2007
• Est. completion date: November 2010

Study information

• Verified date: August 2008
• Source: Toronto Rehabilitation Institute
• Contact: Naaz Kapadia, MSc
• Phone: 416-597-3422
• Email: kapadia.naaz[@]torontorehab.on.ca
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if a form of exercise,known as electrical stimulation can improve walking function and other important health outcomes. The hypothesis is that electrical stimulation can enhance the ability to walk for stroke survivors who are unable to walk on their on their own.

Description:

A stroke is a devastating life event, that can result in permanent disability. Many people who survive a stroke will experience paralysis on one side of their body. The muscles in one leg may become weaker or stiff to the point that the person can barely walk. Functional electrical stimulation (FES) is an intervention that applies short current pulses to muscles and causes them to contract. Previous work done by our team has used FES in the spinal cord injured population to help restore functions such as walking and grasping by contracting groups of paralyzed muscles in an orchestrated manner. This study seeks to explore whether a thrice weekly FES-assisted walking intervention for a 8 week period can stimulate or improve walking ability in individuals with severe lower extremity paralysis secondary to a stroke. This will subsequently promote opportunities for enhanced social participation and quality of life i.e. enhanced balance, increased independence of activities of daily living etc. for stroke consumers. Comparison: 40 individuals with severe hemiplegia will be randomized to either a thrice weekly control (false) FES training regimen OR a thrice weekly intervention (true) FES training regimen. Prior to randomization, participants will be stratified according to their ability to ambulate (walk). This study will determine if FES can improve or enhance walking ability associated with stroke after 8 weeks of training, and after 4-month follow-up period.

Other known NCT identifiers

• NCT00538837

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: November 2010
• Est. primary completion date: October 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 65 Years

Eligibility

Inclusion Criteria:

• Hemiplegic stroke at least 12 months prior to joining the study.

• Age 65 years or greater.

• Ability to follow instructions and to devote his/her attention to therapy.

• Ability to understand instructions in English and able to provide informed consent.

Exclusion Criteria:

• Severe difficulties with attention such that informed consent cannot be obtained, or that safety or communication would be comprised.

• Ability to walk more that 10 meters during a two minute walk with an average speed greater than 0.8 m/s.

• The presence of skin rashes, allergies or bruises where electrodes would be placed.

• History of seizures, edema in paralyzed limbs or co-morbidities such as Parkinson's Disease, cancer or osteoarthritis to be confirmed by attending physiatrist.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Stroke

Intervention

Device:
• Compex Motion Stimulator
'True' Functional Electrical Stimulation Assisted Walking
• Compex Motion Stimulator
'False' FES

Locations

Country	Name	City	State
Canada	Toronto Rehabilitation Institute: Lyndhurst Centre	Toronto	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Toronto Rehabilitation Institute	Heart and Stroke Foundation of Ontario

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The ability of FES-Assisted Walking to stimulate or improve walking ability using a dichotomous outcome i.e. yes/no stimulation or improvement of walking ability on a two-minute walk test.		Test performed weekly during 8-week period as well as at 2 month and 6 month time point.
Secondary	Assessment of balance by completing four tests i.e. move from a seated to a standing position, completion of activities of daily living tasks such as moving from a bed to a wheelchair, standing with eyes opened and closed.		Baseline, 2 month and 6 month period.
Secondary	Bone density at hip, spine, proximal tibia and distal femur using dual-energy xray absorptiometry		Baseline, 2-month and 6-month
Secondary	Assess functional abilities by performing various tasks using our leg and foot as well as your ability to perform functional tasks such as eating, grooming and bathing.		Baseline, 2-month and 6-month time points.